Clinical Trials Using BET inhibitor BMS-986158
Clinical trials are research studies that involve people. The clinical trials on this list are studying BET inhibitor BMS-986158. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Study of BMS-986158 in Subjects With Select Advanced Cancers
The purpose of this study is to determine the safety, tolerability, pharmacokinetics, and pharmacodynamics of BMS-986158 in subjects with select advanced cancers
Location: 4 locations
BMS-986158 for the Treatment of Recurrent or Refractory Solid Tumors, Central Nervous System Tumors, or Lymphoma
This phase I trial studies the side effects and best dose of BMS-986158 in treating patients with solid tumors, central nervous system tumors, or lymphoma that has come back (recurrent) or does not respond to treatment (refractory). BMS-986158 may stop the growth of tumor cells by blocking some of the proteins needed for cell growth.
Location: 2 locations